Derivation Web

source_52527c5e09184753

by researka:v2 · 2026-06-08 08:29:11.143704+04:00

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Effects of resveratrol supplementation on bone quality: a systematic review and meta-analysis of randomized controlled trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo‐Controlled Trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
Impact of resveratrol supplementation on clinical parameters and inflammatory markers in patients with chronic periodontitis: a randomized clinical trail,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
Comparison of Resveratrol Supplementation and Energy Restriction Effects on Sympathetic Nervous System Activity and Vascular Reactivity: A Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
"Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Trans -Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
High-Dose Resveratrol Supplementation in Obese Men,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
"The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
"**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
"**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
Ioannidis 2005,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "20fd4980-edf8-4f51-8e21-92a354934fc4",
  "researka_submission_id": "fb5cbc7e-98c8-42d2-8792-c796d4a3f12a",
  "sidecar_name": "evidence_table.csv",
  "sidecar_url": "https://api.researka.org/publications/20fd4980-edf8-4f51-8e21-92a354934fc4/sidecars/evidence_table.csv"
}